NFKB1 and cancer: Constitutive activation of NF-kB has been shown in various types of cancer; NF-kB leads to a release of adhesion molecules and immune-regulatory cytokines (such as TNF-alpha, IL-1, IL-6 and IL-8), which converge leukocytes to sites of inflammation (88).